“Pass on the Pill or Pass Out” Campaign Warns Women About Addyi

0
447

“The National Women’s Health Network launched the ‘Pass on the Pink Pill – Or Pass Out’ campaign, to warn women of the marginal benefits and serious side effects of the new ‘pink pill’ as drug sales begin. Flibanserin, branded as Addyi – alleged to boost female libido was recently approved by the FDA and bought by Valeant Pharmaceuticals for $1 billion. Valeant is a pharmaceutical giant known for price gouging and shady business practices. Rather than rely on drug company marketing, NWHN recommends that women educate themselves and pass on the pink pill.”

Article →

pass on the pill campaign

Support MIA

MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.

Billing Details

Donation Total: $20 One Time